BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 16470637)

  • 1. Green tea catechins as brain-permeable, natural iron chelators-antioxidants for the treatment of neurodegenerative disorders.
    Mandel S; Amit T; Reznichenko L; Weinreb O; Youdim MB
    Mol Nutr Food Res; 2006 Feb; 50(2):229-34. PubMed ID: 16470637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifunctional activities of green tea catechins in neuroprotection. Modulation of cell survival genes, iron-dependent oxidative stress and PKC signaling pathway.
    Mandel SA; Avramovich-Tirosh Y; Reznichenko L; Zheng H; Weinreb O; Amit T; Youdim MB
    Neurosignals; 2005; 14(1-2):46-60. PubMed ID: 15956814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron and alpha-synuclein in the substantia nigra of MPTP-treated mice: effect of neuroprotective drugs R-apomorphine and green tea polyphenol (-)-epigallocatechin-3-gallate.
    Mandel S; Maor G; Youdim MB
    J Mol Neurosci; 2004; 24(3):401-16. PubMed ID: 15655262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Green tea catechins as brain-permeable, non toxic iron chelators to "iron out iron" from the brain.
    Mandel S; Weinreb O; Reznichenko L; Kalfon L; Amit T
    J Neural Transm Suppl; 2006; (71):249-57. PubMed ID: 17447435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catechin polyphenols: neurodegeneration and neuroprotection in neurodegenerative diseases.
    Mandel S; Youdim MB
    Free Radic Biol Med; 2004 Aug; 37(3):304-17. PubMed ID: 15223064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurological mechanisms of green tea polyphenols in Alzheimer's and Parkinson's diseases.
    Weinreb O; Mandel S; Amit T; Youdim MB
    J Nutr Biochem; 2004 Sep; 15(9):506-16. PubMed ID: 15350981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding the broad-spectrum neuroprotective action profile of green tea polyphenols in aging and neurodegenerative diseases.
    Mandel SA; Amit T; Weinreb O; Youdim MB
    J Alzheimers Dis; 2011; 25(2):187-208. PubMed ID: 21368374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell signaling pathways in the neuroprotective actions of the green tea polyphenol (-)-epigallocatechin-3-gallate: implications for neurodegenerative diseases.
    Mandel S; Weinreb O; Amit T; Youdim MB
    J Neurochem; 2004 Mar; 88(6):1555-69. PubMed ID: 15009657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of action of green tea catechins, with a focus on ischemia-induced neurodegeneration.
    Sutherland BA; Rahman RM; Appleton I
    J Nutr Biochem; 2006 May; 17(5):291-306. PubMed ID: 16443357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Green Tea Catechins Attenuate Neurodegenerative Diseases and Cognitive Deficits.
    Afzal O; Dalhat MH; Altamimi ASA; Rasool R; Alzarea SI; Almalki WH; Murtaza BN; Iftikhar S; Nadeem S; Nadeem MS; Kazmi I
    Molecules; 2022 Nov; 27(21):. PubMed ID: 36364431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting multiple neurodegenerative diseases etiologies with multimodal-acting green tea catechins.
    Mandel SA; Amit T; Kalfon L; Reznichenko L; Youdim MB
    J Nutr; 2008 Aug; 138(8):1578S-1583S. PubMed ID: 18641210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Protective Effects of Green Tea Catechins in the Management of Neurodegenerative Diseases: A Review.
    Farkhondeh T; Yazdi HS; Samarghandian S
    Curr Drug Discov Technol; 2019; 16(1):57-65. PubMed ID: 29468975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell signaling pathways and iron chelation in the neurorestorative activity of green tea polyphenols: special reference to epigallocatechin gallate (EGCG).
    Mandel SA; Amit T; Kalfon L; Reznichenko L; Weinreb O; Youdim MB
    J Alzheimers Dis; 2008 Oct; 15(2):211-22. PubMed ID: 18953110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurorescue activity, APP regulation and amyloid-beta peptide reduction by novel multi-functional brain permeable iron- chelating- antioxidants, M-30 and green tea polyphenol, EGCG.
    Avramovich-Tirosh Y; Reznichenko L; Mit T; Zheng H; Fridkin M; Weinreb O; Mandel S; Youdim MB
    Curr Alzheimer Res; 2007 Sep; 4(4):403-11. PubMed ID: 17908043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel bifunctional drugs targeting monoamine oxidase inhibition and iron chelation as an approach to neuroprotection in Parkinson's disease and other neurodegenerative diseases.
    Youdim MB; Fridkin M; Zheng H
    J Neural Transm (Vienna); 2004 Oct; 111(10-11):1455-71. PubMed ID: 15480846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial Effects of Green Tea Catechins on Neurodegenerative Diseases.
    Pervin M; Unno K; Ohishi T; Tanabe H; Miyoshi N; Nakamura Y
    Molecules; 2018 May; 23(6):. PubMed ID: 29843466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel approach of proteomics and transcriptomics to study the mechanism of action of the antioxidant-iron chelator green tea polyphenol (-)-epigallocatechin-3-gallate.
    Weinreb O; Amit T; Youdim MB
    Free Radic Biol Med; 2007 Aug; 43(4):546-56. PubMed ID: 17640565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurodegenerative diseases and therapeutic strategies using iron chelators.
    Ward RJ; Dexter DT; Crichton RR
    J Trace Elem Med Biol; 2015; 31():267-73. PubMed ID: 25716300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Review on the neuroprotective effects of green tea polyphenols for the treatment of neurodegenerative diseases].
    Li Q; Li Y
    Wei Sheng Yan Jiu; 2010 Jan; 39(1):123-6. PubMed ID: 20364607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron dysregulation in Alzheimer's disease: multimodal brain permeable iron chelating drugs, possessing neuroprotective-neurorescue and amyloid precursor protein-processing regulatory activities as therapeutic agents.
    Mandel S; Amit T; Bar-Am O; Youdim MB
    Prog Neurobiol; 2007 Aug; 82(6):348-60. PubMed ID: 17659826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.